Fiche société
faida agili
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic DiseasesAn observational study aiming to assess the serological profile of SARS-Cov2 patients with systemic diseases such as systemic lupus erythematosus, Sjogren syndrome, sarcoidosis, inflammatory myopathies, Behçet's disease, Rheumatoid arthritis and Spondyloarthritis | Lupus | À vérifier | Immunomodulation | Tunisia | À vérifier |
| Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic DiseasesAn observational study aiming to assess the serological profile of SARS-Cov2 patients with systemic diseases such as systemic lupus erythematosus, Sjogren syndrome, sarcoidosis, inflammatory myopathies, Behçet's disease, Rheumatoid arthritis and Spondyloarthritis | Lupus | À vérifier | Immunomodulation | Tunisia | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases | Lupus | À vérifier | NCT04530461 | Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases | UNKNOWN |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||